Olfr630 Inhibitors
Olfr630, a member of the olfactory receptor family, plays a crucial role in the intricate process of olfactory signal transduction. Positioned within the nasal epithelium, Olfr630 functions as a G-protein-coupled receptor (GPCR), pivotal for detecting and transducing diverse odorant signals. Olfactory receptors, including Olfr630, are integral to the initial steps of olfaction, allowing organisms to perceive and distinguish a vast array of smells in their environment. The activation of Olfr630 initiates a signaling cascade within olfactory sensory neurons, ultimately leading to the transmission of olfactory information to higher brain centers for interpretation.
Inhibition of Olfr630 involves a sophisticated interplay of chemical compounds targeting key cellular pathways associated with its function. These inhibitors act either directly on Olfr630 or indirectly by modulating crucial signaling pathways. For instance, histone deacetylase inhibitors, such as Suberoylanilide Hydroxamic Acid, impact Olfr630 gene expression by modifying the epigenetic landscape. Other inhibitors, like those targeting p38 MAP kinase or PI3K-Akt pathway, indirectly influence Olfr630 by disrupting intracellular signaling, thereby altering the receptor's responsiveness to odorants. Additionally, inhibitors affecting NF-κB signaling may regulate Olfr630 expression through modulation of inflammatory responses. The diverse mechanisms of inhibition underscore the intricate nature of olfactory receptor regulation and highlight the multifaceted approaches employed to modulate Olfr630 function within the olfactory system.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, a histone deacetylase (HDAC) inhibitor, disrupts chromatin structure, leading to altered gene expression. It influences Olfr630 indirectly by modifying the epigenetic landscape, impacting the accessibility of the receptor's gene. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, a signaling pathway associated with Olfr630 function. By disrupting p38 signaling, this compound indirectly influences Olfr630, impacting downstream cellular responses involved in olfactory signal transduction. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. Its action on the PI3K-Akt pathway indirectly affects Olfr630 by modulating intracellular signaling, altering the receptor's responsiveness to odorant molecules. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Bay 11-7082 inhibits NF-κB activation, a pathway linked to Olfr630. Its influence on NF-κB signaling indirectly impacts Olfr630, suggesting a role in regulating the receptor's expression or function through modulation of inflammatory responses. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK (c-Jun N-terminal kinase) inhibitor. By targeting the JNK signaling pathway, it indirectly affects Olfr630, potentially modulating cellular processes associated with olfactory signal transduction. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2 in the MAPK pathway. Its action on this pathway indirectly influences Olfr630, altering downstream components and cellular responses associated with olfactory signal transduction. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
All-trans retinoic acid (ATRA), a retinoid, influences Olfr630 indirectly by modulating retinoic acid receptors (RARs). RARs may impact gene expression patterns related to olfactory receptor regulation, affecting Olfr630 responsiveness. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective MEK inhibitor, targeting the MAPK pathway. Its action on MEK influences Olfr630 indirectly, suggesting a role in regulating the receptor's responsiveness to odorants by modulating intracellular signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor. Its impact on the PI3K-Akt pathway indirectly influences Olfr630, potentially altering the receptor's function by modulating intracellular signaling pathways associated with olfactory signal transduction. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Sulfasalazine inhibits NF-κB activation, impacting the NF-κB signaling pathway associated with Olfr630. Its indirect influence on Olfr630 suggests a role in modulating the receptor's expression or function through regulation of inflammatory responses. | ||||||